- Home
- SHLS vs SIBN Comparison
SHLS vs SIBN Comparison
Compare SHLS & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLS
- SIBN
- Stock Information
- Founded
- SHLS 1996
- SIBN 2008
- Country
- SHLS United States
- SIBN United States
- Employees
- SHLS N/A
- SIBN N/A
- Industry
- SHLS Semiconductors
- SIBN Medical/Dental Instruments
- Sector
- SHLS Technology
- SIBN Health Care
- Exchange
- SHLS Nasdaq
- SIBN Nasdaq
- Market Cap
- SHLS 633.5M
- SIBN 571.0M
- IPO Year
- SHLS 2021
- SIBN 2018
- Fundamental
- Price
- SHLS $6.19
- SIBN $18.91
- Analyst Decision
- SHLS Buy
- SIBN Strong Buy
- Analyst Count
- SHLS 23
- SIBN 5
- Target Price
- SHLS $9.34
- SIBN $24.40
- AVG Volume (30 Days)
- SHLS 7.1M
- SIBN 498.1K
- Earning Date
- SHLS 05-06-2025
- SIBN 05-05-2025
- Dividend Yield
- SHLS N/A
- SIBN N/A
- EPS Growth
- SHLS N/A
- SIBN N/A
- EPS
- SHLS 0.11
- SIBN N/A
- Revenue
- SHLS $388,762,000.00
- SIBN $176,601,000.00
- Revenue This Year
- SHLS $8.96
- SIBN $19.30
- Revenue Next Year
- SHLS $11.92
- SIBN $15.28
- P/E Ratio
- SHLS $55.44
- SIBN N/A
- Revenue Growth
- SHLS N/A
- SIBN 22.60
- 52 Week Low
- SHLS $2.71
- SIBN $11.70
- 52 Week High
- SHLS $8.52
- SIBN $19.16
- Technical
- Relative Strength Index (RSI)
- SHLS 85.18
- SIBN 77.50
- Support Level
- SHLS $3.65
- SIBN $18.35
- Resistance Level
- SHLS $6.46
- SIBN $19.35
- Average True Range (ATR)
- SHLS 0.34
- SIBN 0.77
- MACD
- SHLS 0.24
- SIBN 0.53
- Stochastic Oscillator
- SHLS 86.86
- SIBN 90.12
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.